Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Kobrin

Showing results (61-70 of 129) with videos related to

Pageof 13
Sort By:
Journal of the American College of Cardiology|February 1, 1996
Effects of a new calcium antagonist, mibefradil (Ro 40-5967), on silent ischemia in patients with stable chronic angina pectoris: a multicenter placebo-controlled study. The Mibefradil International Study GroupS Braun, E E van der Wall, H Emanuelsson, et al.
Archives of Internal Medicine|February 1, 1986
Renal involvement follows cardiac enlargement in essential hypertensionI Kobrin, E D Frohlich, H O Ventura, et al.
Israel Journal of Medical Sciences|March 1, 1983
Acute oral management of hypertension: blood pressure response to prazosin and nifedipineY Yagil, I Kobrin, J Stessman, et al.
Journal of Cardiovascular Pharmacology|January 1, 1993
Comparison of verapamil and captopril in elderly hypertensive subjects: results of a randomized, double-blind, crossover studyM Bursztyn, J Ghanem, I Kobrin, et al.
Journal of Cardiovascular Pharmacology|January 1, 1991
The effect of cilazapril, a new angiotensin converting enzyme inhibitor, on peak and trough blood pressure measurements in hypertensive patientsP Güntzel, I Kobrin, C Pasquier, et al.
Journal of Cardiovascular Pharmacology|January 1, 1988
Nitrendipine prevents the development of cardiac hypertrophy in DOCA-salt-treated hypertension-prone (SBH) and -resistant (SBN) rats through nonhemodynamic mechanismsI Kobrin, R Waksman, J Mekler, et al.
The American Journal of Cardiology|August 21, 1997
Mibefradil in the treatment of systemic hypertension: comparative studies with other calcium antagonistsB M Massie, Y Lacourcière, R Viskoper, et al.
Postgraduate Medical Journal|January 1, 1983
The combination of propranolol and nifedipine in the treatment of hypertension: acute and long term effectsY Yagil, B Leibel, I Kobrin, et al.
Fiziologicheskii Zhurnal|May 1, 1991
[Prevention of myocardial reperfusion injury by increasing artificial trans-membrane sodium gradient in "calcium paradox" and post-ischemic reperfusion]V V Alabovskiĭ, A A Vinokurov, V I Kobrin, et al.
Vrachebnoe Delo|February 1, 1976
[Remote results of lung resection in suppurative diseases]S B Sokolov, A V Alekseenko, L I Kobrin, et al.
Pageof 13

Showing results (61-70 of 129) with videos related to

Sort By:
Pageof 13
Journal of the American College of Cardiology|February 1, 1996
Effects of a new calcium antagonist, mibefradil (Ro 40-5967), on silent ischemia in patients with stable chronic angina pectoris: a multicenter placebo-controlled study. The Mibefradil International Study GroupS Braun, E E van der Wall, H Emanuelsson, et al.
Archives of Internal Medicine|February 1, 1986
Renal involvement follows cardiac enlargement in essential hypertensionI Kobrin, E D Frohlich, H O Ventura, et al.
Israel Journal of Medical Sciences|March 1, 1983
Acute oral management of hypertension: blood pressure response to prazosin and nifedipineY Yagil, I Kobrin, J Stessman, et al.
Journal of Cardiovascular Pharmacology|January 1, 1993
Comparison of verapamil and captopril in elderly hypertensive subjects: results of a randomized, double-blind, crossover studyM Bursztyn, J Ghanem, I Kobrin, et al.
Journal of Cardiovascular Pharmacology|January 1, 1991
The effect of cilazapril, a new angiotensin converting enzyme inhibitor, on peak and trough blood pressure measurements in hypertensive patientsP Güntzel, I Kobrin, C Pasquier, et al.
Journal of Cardiovascular Pharmacology|January 1, 1988
Nitrendipine prevents the development of cardiac hypertrophy in DOCA-salt-treated hypertension-prone (SBH) and -resistant (SBN) rats through nonhemodynamic mechanismsI Kobrin, R Waksman, J Mekler, et al.
The American Journal of Cardiology|August 21, 1997
Mibefradil in the treatment of systemic hypertension: comparative studies with other calcium antagonistsB M Massie, Y Lacourcière, R Viskoper, et al.
Postgraduate Medical Journal|January 1, 1983
The combination of propranolol and nifedipine in the treatment of hypertension: acute and long term effectsY Yagil, B Leibel, I Kobrin, et al.
Fiziologicheskii Zhurnal|May 1, 1991
[Prevention of myocardial reperfusion injury by increasing artificial trans-membrane sodium gradient in "calcium paradox" and post-ischemic reperfusion]V V Alabovskiĭ, A A Vinokurov, V I Kobrin, et al.
Vrachebnoe Delo|February 1, 1976
[Remote results of lung resection in suppurative diseases]S B Sokolov, A V Alekseenko, L I Kobrin, et al.
Pageof 13